Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) are two of the bioscience companies that are facilitating global vaccines. I'm bullish on Pfizer but bearish on Moderna. See Top Smart Score Stocks >> Using TipRanks' Stock Comparison tool, we can compare the two vaccine stocks. Pfizer Pfizer was already producing stellar financial results prior to COVID-19; in 2019, operating income grew by 13.29%, with the company's wide range of approved drugs contributing to growth. In 2020, Pfizer spent a lot of capital on Research & Development for the COVID-19 vaccine, which meant that operating income didn't improve all that much in 2020 (+20.89%), even after the vaccine rollout started.
https://www.tipranks.com/news/article/a-battle-between-two-vaccine-makers?utm_source=advfn.com&utm_medium=referral
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Moderna Charts.